Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Capital Expenditures (2020 - 2023)

Journey Medical filings provide 3 years of Capital Expenditures readings, the most recent being $5.0 million for Q1 2023.

  • On a quarterly basis, Capital Expenditures fell 75.0% to $5.0 million in Q1 2023 year-over-year; TTM through Dec 2023 was $5.0 million, a 75.0% decrease, with the full-year FY2024 number at $15.0 million, up 200.0% from a year prior.
  • Capital Expenditures hit $5.0 million in Q1 2023 for Journey Medical, down from $20.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $20.0 million in Q1 2022 to a low of $4.1 million in Q4 2020.
  • Median Capital Expenditures over the past 3 years was $5.0 million (2023), compared with a mean of $9.7 million.
  • The widest YoY moves for Capital Expenditures: up 75.0% in 2023, down 75.0% in 2023.
  • Journey Medical's Capital Expenditures stood at $4.1 million in 2020, then soared by 382.51% to $20.0 million in 2022, then crashed by 75.0% to $5.0 million in 2023.
  • The last three reported values for Capital Expenditures were $5.0 million (Q1 2023), $20.0 million (Q1 2022), and $4.1 million (Q4 2020) per Business Quant data.